In contrast to External Beam Radiotherapy (EBRT) in which high-energy x-rays are directed at the tumor from outside the body, Electronic Brachytherapy (braykee-thera-pea) involves the precise placement of radiation directly at the site of the tumor.
Electronic brachytherapy treatment offers doctors the ability to protect normal tissue while delivering a targeted dose of radiation precisely to the affected area. This type of precision, previously not possible, minimizes damage to surrounding tissue.
Scientists at prestigious medical schools recognize the clinical value of collaborative investigations that arise from the “one medicine” model supported by the New York Veterinary Foundation, and the potential benefit to their patients.
Working in collaboration with researchers at human medical centers who are already treating breast cancer with this newly developed “precision guided low dose” radiation therapy, NYVF is funding research on models for treating brain nasal, skin and spinal tumors in pets using electronic brachytherapy.
At the New York Veterinary Foundation, we refer to research as the “clinical study of naturally occurring diseases” that impact both veterinary and human patients. Thus, we study data that is derived from patients that are being treated when they are ill, rather than generated in controlled laboratory situations. This information is then reported and presented to both medical and veterinary doctors, bridging the divide between human and veterinary medicine.


Chiari malformation is a condition wherein the skull is misshaped or simply too small causing part of the brain, the cerebellum, to descend out of the skull through the opening at its base, crowding the spinal cord.